Hers vs Hims GLP-1: Which One Actually Fits You Now?
Disclosure: This page contains affiliate links. If you sign up through one of our links, we may earn a commission at no extra cost to you. This does not influence our recommendations. Full editorial standards.
This content is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any weight loss medication.
If you're searching for Hers vs Hims GLP-1, here's the fast answer: they are not competitors. Hers and Hims are two brands under the same parent company — Hims & Hers Health, Inc. (NYSE: HIMS) — with a very similar cash-pay telehealth model for weight loss.
That means the question isn't really "which one is better." It's whether Hims & Hers is the right GLP-1 provider for you at all — especially after the major changes that hit this platform in early 2026.
But "same parent company" does not mean "everything is identical." The live consumer pages, pricing, and medication emphasis are in active transition right now. What you see on the Hims website and the Hers website may not match perfectly, and neither may match the latest corporate announcements. We break all of that down below.
We verified pricing, medication availability, cancellation policies, and state restrictions against official Hims and Hers pages, FDA records, and the March 9, 2026 Novo Nordisk partnership announcement. Below, we walk through what you'd actually pay, what medications you'd get, the fine print on canceling, and when you're better off going somewhere else entirely.
Quick Verdict
- Choose Hers if you're a woman who wants fast, virtual-only access to GLP-1 weight loss medication and you're comfortable paying cash with no insurance.
- Choose Hims if you're a man who wants the same model through a men's health-focused interface.
- Choose neither if your insurance covers brand-name GLP-1s, you want month-to-month flexibility, or you want more hands-on support than an app-and-messaging care model provides.
What's confirmed today vs. what's still in transition
Confirmed
Same parent company. No insurance accepted. HSA/FSA reimbursement model. 48-hour cancellation timing. No returns. Multi-month paid-in-full plans are standard. GLP-1 availability is not in all 50 states.
Still in transition
Exact pricing alignment between Hims and Hers consumer pages. The live role and availability of compounded semaglutide. Timing and visibility of oral Wegovy across consumer pages. Brand-name pricing is still shifting as the Novo Nordisk partnership rolls out.
What's the Fastest Way to Compare Hers vs Hims for GLP-1?
This table cuts through the noise. We checked each row against official Hims and Hers pages on March 16, 2026.
| Feature | Hers (forhers.com) | Hims (hims.com) |
|---|---|---|
| Parent company | Hims & Hers Health, Inc. (NYSE: HIMS) | Hims & Hers Health, Inc. (NYSE: HIMS) |
| Target audience | Women | Men |
| Brand-name GLP-1 options | Ozempic, Wegovy prominently; Mounjaro, Zepbound, generic liraglutide in informational content | Ozempic, Wegovy, Mounjaro, Zepbound, generic liraglutide on the main weight-loss page |
| Compounded semaglutide | Referenced; being limited to clinically necessary cases per March 2026 announcement | Same — referenced; being phased down per March 2026 announcement |
| Non-GLP-1 oral weight loss kits | Yes — bupropion, metformin, naltrexone, topiramate, B12 | Yes — same medication categories |
| Wegovy pricing (brand-name) | ~$599/mo on 6-month plan paid upfront ($3,594 total) | $599/mo 6-month plan ($3,594); $649/mo 3-month plan |
| Compounded semaglutide pricing | From $199/mo on 6-month plan (availability in transition) | From $199/mo on 6-month plan (availability in transition) |
| Oral weight loss kit pricing | From $69/mo on 10-month plan paid upfront | From $69/mo on 10-month plan paid upfront |
| Insurance accepted | No | No |
| HSA/FSA eligible | Yes (reimbursement model) | Yes (reimbursement model) |
| Upfront payment | Yes — most plans are multi-month prepaid | Yes — most plans are multi-month prepaid |
| Returns/refunds | Not accommodated | Not accommodated |
| Provider access | Provider messaging, medication adjustments, progress tools, sleep/nutrition/exercise guidance | 24/7 care-team access, monthly check-ins, medication adjustments, sleep/nutrition/exercise guidance |
| Available in all 50 states | No | No |
Most high-level features are similar because both brands sit under the same parent company. But the live pages are not identical — the medication emphasis, pricing presentation, and support language differ in the details. The provider ultimately determines what medication and plan you receive, regardless of which brand you enter through.
So let's stop comparing Hers to Hims and start answering what actually matters: Is this platform the right fit for you?
Who Should Choose Hers, Who Should Choose Hims, and Who Should Choose Neither?
This is the section that saves you the most time.
Choose Hers if:
- You want the women-focused experience — Hers frames its content, app, and community around women's health
- You're comfortable with a fully online, app-based program
- You're paying cash (no insurance) and can commit to a multi-month prepaid plan
- You want access to brand-name GLP-1s like Wegovy without navigating insurance
- You already use other Hers products and like keeping everything under one account
Choose Hims if:
- You want the men-focused experience — Hims positions its weight loss within a broader men's health platform
- You're comfortable with the same online-first, cash-pay model
- You prefer having weight loss, hair loss, and other health treatments on a single platform
- You want a similar medication and pricing model to Hers, with men-focused branding
Choose neither if:
- Your insurance already covers brand-name GLP-1s. If your health plan covers Wegovy or Zepbound with a manageable copay, going through your PCP or an endocrinologist will almost certainly cost less than cash-pay telehealth. Don't pay $599/month out of pocket when your plan might cover it for $25–$150.
- You want month-to-month flexibility. Hims & Hers requires multi-month prepaid commitments on most plans, and refunds are not accommodated. If you're not sure GLP-1 medication will work for you, locking into months of prepaid charges is a real financial risk. Other providers offer month-to-month options.
- You want scheduled live coaching, in-person obesity medicine, or more hands-on support. The Hims & Hers model includes provider messaging, check-ins, and app-based guidance — but it is not a structured coaching program with regular live appointments.
- You have a complex medical history. GLP-1 medications carry contraindications (personal or family history of medullary thyroid carcinoma or MEN2) and warnings (pancreatitis, gallbladder problems) per FDA labeling. If you have conditions that require careful screening, you want a provider who does a thorough workup.
- You're in a restricted state. Hims & Hers GLP-1 services are not available in all 50 states. Additionally, compounded semaglutide has its own separate state-eligibility list. Check the platform directly before investing time in the intake process.
We're being this direct because the honest answer matters more than a safe "it depends." If Hims & Hers isn't the best fit, we'd rather point you somewhere better.
Compare Top GLP-1 Providers
Want more flexibility? We verified pricing on multiple GLP-1 programs
- Lower cost options from $129/mo
- Month-to-month billing available
- Insurance navigation support
- Higher customer satisfaction ratings
What Changed With Hims and Hers GLP-1 in 2026?
This is the part most comparison articles haven't caught up with yet. If you're reading reviews from 2024 or early 2025, the information is materially outdated.
The timeline that matters
May 20, 2024
Hims & Hers announces access to compounded GLP-1 injections starting at $199/month. (Source: Hims & Hers investor announcement)
February 21, 2025
The FDA announces that the semaglutide injection shortage is resolved — significant because the shortage was the legal basis for mass compounding. (Source: FDA)
September 9, 2025
The FDA sends a warning letter to Hers over compounded semaglutide marketing claims. (Source: FDA Warning Letter)
February 5, 2026
Hims & Hers announces a compounded semaglutide pill at $49/month introductory pricing. Novo Nordisk responds immediately, calling it "illegal mass compounding." (Source: Reuters)
February 7, 2026
The FDA announces plans to restrict access to GLP-1 active pharmaceutical ingredients used in compounding. Hims stops offering the compounded semaglutide pill. (Source: Reuters)
March 9, 2026
The pivot. Hims & Hers announces a strategic shift: stop advertising compounded GLP-1s, move toward FDA-approved GLP-1s, keep compounded access only when clinically necessary. Novo Nordisk collaboration announced. (Source: Hims & Hers investor announcement)
Why this matters for your decision right now
The company says it is shifting its U.S. weight-loss offering toward a broader assortment of FDA-approved GLP-1s, while limiting compounded semaglutide to cases where a provider determines it is clinically necessary.
If you're a new customer:
The platform is emphasizing brand-name options like Wegovy. What you're offered will depend on your provider's clinical judgment, your state, and current availability.
If you're an existing compounded customer:
Hims & Hers says existing patients will have the opportunity to transition to FDA-approved medications "when clinically appropriate." Your pricing and dosing may change.
If you're reading older reviews:
Any review that leads with "$199/month compounded semaglutide" as the primary offering was written before this shift. Compounded access is no longer the flagship offer.
Why you're seeing conflicting information right now
The official Hims and Hers consumer-facing websites haven't fully caught up with the corporate announcements. As of mid-March 2026, some pages still reference compounded semaglutide and $199 starting prices, while investor communications describe a shift away from compounded GLP-1 advertising.
This is a transition period. What you see on the website, what the investor relations page says, and what a provider tells you during intake may not perfectly align right now.
Our advice: Don't rely on marketing pages for your pricing expectations. During the intake process, ask your provider directly: What specific medication will I receive? What will I actually pay? Is this compounded or brand-name? Get clarity before you commit money.
How Much Does Hims & Hers Weight Loss Actually Cost in 2026?
This is where we get specific. "Starting at" pricing is marketing. Let's talk about what you'd really pay.
Current pricing we could verify (checked March 16, 2026)
| Treatment | Listed Monthly Cost | Typical Commitment | Day-One Cost | Source/Notes |
|---|---|---|---|---|
| Oral weight loss kit (non-GLP-1) | From $69/mo | 10-month plan, paid upfront | ~$690 | Hims and Hers drug-pricing pages. Includes bupropion, metformin, naltrexone, topiramate, B12. Compounded, not FDA-approved as a finished combination. |
| Compounded semaglutide injection | From $199/mo | 6-month plan, paid upfront | ~$1,194 | Being phased down. Not FDA-approved. Availability in transition. |
| Brand-name Wegovy (injectable) | $599/mo (6-mo) / $649/mo (3-mo) | Multi-month, paid upfront | $3,594 or $1,947 | Hims Wegovy page. Promo pricing may be available for new customers. |
| Novo Nordisk direct (NovoCare) | $499/mo | No multi-month prepay required | $499 | For comparison — Novo's own self-pay pharmacy, available to all eligible cash-paying patients. |
Prices are what we found on live pages as of March 16, 2026. Pricing for Mounjaro, Zepbound, and oral Wegovy through the Hims & Hers platform was not clearly listed on the consumer pages we checked. Actual price depends on the product and plan you purchase.
The costs that don't make the ad
- Lab work: Not always required, but if your provider flags a concern, expect to pay out of pocket. Labs are not included in the plan price.
- HSA/FSA: Plans are eligible, but this is typically a reimbursement model — you pay with a regular card, download your receipt, and submit for reimbursement. Don't assume your HSA debit card will work at checkout. Hims estimates average HSA/FSA tax savings at about 30%.
- Prepaid plans are non-refundable. If you sign up for a 6-month Wegovy plan at $3,594 and quit after month two, you've paid for six months.
- Shorter plans cost more per month. A 3-month Wegovy plan runs $649/month while the 6-month drops to $599/month. The per-month savings come with bigger upfront commitment and more risk.
What HSA/FSA actually saves you (with real math)
If you're in the 24% federal tax bracket and you pay with HSA funds:
$69/mo oral kit (10mo)
$690
~$524
with HSA
$199/mo compounded (6mo)
$1,194
~$907
with HSA
$599/mo Wegovy (6mo)
$3,594
~$2,731
with HSA
The savings are meaningful — but HSA/FSA doesn't change the non-refundable nature of the plan.
How Hims & Hers pricing compares to the broader market
- Novo Nordisk direct (NovoCare): $499/mo for self-pay patients. No multi-month prepay required.
- Wegovy with commercial insurance: $25–$150/month copay for patients whose plans cover it (highly variable by plan).
- Competitive telehealth GLP-1 providers: $129–$249/month for various programs, some with month-to-month billing and no long-term prepay.
- Wegovy retail price without insurance: ~$1,350/month at list price.
Hims & Hers Wegovy at $599/month is more expensive than Novo's own $499/month direct channel. The value-add is the bundled telehealth support: provider messaging, medication adjustments, and app-based guidance. Whether that justifies the $100/month premium is a personal call.
The honest takeaway: Hims & Hers is significantly cheaper than retail list price. But for brand-name Wegovy specifically, Novo's own direct self-pay option is cheaper. And if your insurance covers GLP-1s, your doctor's office is almost certainly the best deal. The prepaid structure means your real financial risk is the full plan cost, not the monthly rate.
What Medications Can You Actually Get Through Hers and Hims Right Now?
The medication menu has shifted. Here's what each platform's current public pages reference as of March 2026.
What Hims currently lists
Hims' main weight-loss page explicitly lists Ozempic, Wegovy, Mounjaro, Zepbound, and generic liraglutide. It also references compounded semaglutide injections and oral medication kits with non-GLP-1 ingredients.
What Hers currently lists
Hers' current public weight-loss content clearly promotes Ozempic and Wegovy. Informational content also references Mounjaro, Zepbound, and generic liraglutide. Hers also offers the same oral medication kits and compounded semaglutide options.
In all cases, the provider decides what is appropriate
"Available on the platform" does not mean "you will receive this medication." Your provider reviews your intake and determines what's medically appropriate. You might complete the questionnaire expecting Wegovy and get prescribed an oral kit instead.
This trips up a lot of people. Some users sign up expecting injectable GLP-1s and receive the $69/month oral kit instead. Others expect brand-name and receive compounded. The platform shows you the full menu; the provider decides what you get based on your health profile, state regulations, and current availability.
Practical tip: During the intake process, be specific about what you want. If brand-name Wegovy is your goal, say so. Ask your provider what medication they're recommending and why. You have the right to understand your treatment plan before you pay.
Compounded vs. brand-name: what you need to know
Brand-name GLP-1s
Ozempic, Wegovy, Mounjaro, Zepbound — FDA-approved. Manufactured under strict quality controls. Dosing is consistent. Safety profile is well-studied in large clinical trials. This is the gold standard.
Compounded semaglutide
Not FDA-approved as a finished product. The FDA does not verify compounded drugs for safety, effectiveness, or quality before marketing. Unnecessary use can expose patients to serious risks. The FDA has reported dosing errors with compounded semaglutide that led to adverse events, including some hospitalizations.
With the March 2026 transition toward brand-name medications on the Hims & Hers platform, this concern is actively being addressed. If you have the option between compounded and brand-name, brand-name is the safer choice.
Understanding off-label prescribing
Ozempic and Mounjaro are FDA-approved for type 2 diabetes, not weight management. When prescribed for weight loss, that's called off-label prescribing — legal and common in medicine. The weight-loss-approved versions are Wegovy (semaglutide) and Zepbound (tirzepatide). Through Hims & Hers, which doesn't accept insurance, this distinction mostly affects your provider's clinical decision-making rather than your wallet.
What Is the Experience Actually Like After You Sign Up?
We want you to know exactly what you're walking into.
Online intake
You fill out a health questionnaire covering your medical history, current medications, weight, BMI, and weight loss goals.
Provider review
A licensed clinician reviews your intake. In most states, this happens asynchronously — the provider reads your form, makes a determination, and messages you. Some states require a video or phone visit.
Labs (sometimes)
Not standard. If your provider flags a concern (thyroid, liver, blood sugar), labs may be required at additional cost out of pocket.
Medication delivery
If approved, medication ships to your door. Injectable GLP-1s need proper refrigeration during shipping — worth verifying when your package arrives.
Ongoing support
Hims advertises 24/7 care-team access, monthly check-ins, medication adjustments, and guidance on sleep, nutrition, and exercise. Hers advertises unlimited provider messaging and ongoing support. Both platforms have app-based content for nutrition, movement, and sleep.
What to realistically expect for weight loss
Hers' current weight-loss page reports: Customers lost an average of 11.1 lbs with compounded GLP-1 injections and 7.9 lbs with oral medication kits in the first two months, alongside a reduced-calorie diet and exercise. These are self-reported results and were not independently verified.
Clinical trial data for brand-name medications:
- • Patients on Wegovy (semaglutide 2.4mg) lost an average of ~15% of their body weight over 68 weeks — roughly 34 lbs for someone starting at 230 lbs
- • Patients on Zepbound (tirzepatide 15mg) lost an average of ~22% of their body weight over 72 weeks — roughly 52 lbs for someone starting at 230 lbs
The catch nobody wants to talk about
Research shows patients regain approximately two-thirds of their lost weight within a year after stopping semaglutide. GLP-1 medications are designed for long-term use — not a "take it for six months and you're done" solution. If you're budgeting for a 6-month plan, understand that stopping may mean regaining much of your progress unless you've built sustainable habits alongside the medication.
This is where the care model matters. Hims & Hers includes provider messaging, app-based nutrition and movement content, and monthly check-ins. But this is not the same as structured coaching with a dietitian or behavioral therapist. If you're planning to eventually come off the medication, having a strong lifestyle foundation matters — and some competing programs invest more heavily in that support.
What Happens If You Stop Taking GLP-1 Medication?
This question doesn't get enough attention, but it should — because it affects whether a 6-month prepaid plan is really "enough."
GLP-1 medications work by mimicking a hormone that signals fullness to your brain, slows stomach emptying, and reduces appetite. When you stop taking the medication, those signals go away. The appetite suppression fades. The hunger returns. For most people, this happens within weeks.
Published research on semaglutide withdrawal shows patients regained roughly two-thirds of the weight they'd lost within 12 months after stopping. This doesn't mean the medication "didn't work" — it means GLP-1s manage obesity the way blood pressure medication manages hypertension. Stop taking it, and the condition tends to return. Learn more about GLP-1 discontinuation.
What this means for your budget
If you're treating this as a short-term fix — "I'll take it for six months and then maintain on my own" — you should know the odds are against that plan unless you've simultaneously built serious exercise and nutrition habits. Many patients stay on GLP-1 medication for years. Budget accordingly.
What this means for your provider choice
A provider that helps you build lasting habits alongside the medication may deliver more durable results than one that simply ships the drug and lets you figure out the rest. This is worth factoring into your decision.
Practical Questions That Would Otherwise Send You Back to Search
These are the edge-case questions that most comparison pages skip — and the reason people end up searching again after reading one.
Can you switch from Hers to Hims (or vice versa)?
Since they're under the same parent company, there's no clinical reason to "switch." The medication and general care model are comparable. If you want a fundamentally different experience, you'd need to switch to an entirely different provider.
What if the medication isn't working for me?
You can message your provider through the app to discuss dose adjustments or a medication change. Both platforms advertise that providers can modify your treatment plan based on your progress. However, changing medication doesn't change the financial commitment — your prepaid plan stays in effect regardless.
Can I get both the oral kit and GLP-1 injections?
Your provider determines your treatment plan. Some patients start on the oral kit and later transition to GLP-1 injections. The pricing would be separate — you'd be on a different plan with different costs.
What if I'm already on a GLP-1 from another provider?
You can sign up for Hims or Hers and go through their intake process. Your new provider will review your history and determine the appropriate plan. Be aware: you'd be starting a new prepaid commitment, and your dosing may be adjusted based on their clinical judgment.
How does Hims & Hers compare to just going to my doctor?
If your insurance covers GLP-1 medications, your doctor is almost always cheaper. The advantage of Hims & Hers is speed and convenience for people paying cash — no referrals, no insurance navigation, no waiting for prior authorization. The disadvantage is cost (especially for brand-name Wegovy at $599/month vs. a $25–$150 insurance copay) and the level of medical oversight.
What about the new GLP-1 pills coming to market?
Eli Lilly's orforglipron — an oral GLP-1 pill — is expected to seek FDA approval in 2026. If approved, it could significantly expand the oral GLP-1 market. This is a fast-moving market. What's available today may look different in six months.
Are Hims and Hers Actually Different, or Is It the Same Platform?
Let's settle this clearly.
What's the same
- • Same parent company. Hims & Hers Health, Inc. launched Hims in 2017 for men's health and added Hers in 2018 as the women-focused brand.
- • Broadly similar telehealth model. Cash-pay, online intake, provider messaging, medication shipped to your door.
- • Overlapping policies. No-insurance, HSA/FSA reimbursement, multi-month prepaid, no-returns.
What's different
- • Branding and messaging. Hers uses wellness-focused language for women. Hims leans into confidence-driven messaging for men.
- • Adjacent health offerings. Hers offers birth control, skincare, women's sexual health. Hims offers ED medication, hair loss, men's sexual health.
- • Live pages differ in details. Medication listings, pricing presentation, and support language are not identical between hims.com and forhers.com.
Don't overpay for brand differentiation that doesn't change the core care model. If you're a woman, use Hers. If you're a man, use Hims. But don't spend hours comparing them feature-by-feature — the real comparison worth your time is Hims & Hers vs. the broader GLP-1 market.
Which Option Is Safer and More Legitimate?
Since Hers and Hims are under the same parent company, safety is about the program itself, not one brand versus the other.
Is Hims & Hers a scam?
No. They are a publicly traded company (NYSE: HIMS) with licensed providers, real medications, and regulatory oversight. Being listed on a stock exchange means quarterly financial audits, SEC reporting, and public accountability. That said, the company has faced real regulatory scrutiny: the FDA sent a warning letter to Hers about compounded semaglutide marketing claims (September 2025). Novo Nordisk pursued legal action, resolved through a partnership in March 2026. The company is legitimate — but "legitimate" and "best choice" are different things.
Side effects to know about (all GLP-1 medications)
Common (usually mild, often improve over weeks)
Nausea (most reported, especially during dose increases), constipation or diarrhea, headache, fatigue, vomiting, reduced appetite.
Serious (rare but real — from FDA prescribing information)
- • Thyroid tumors — boxed warning. Contraindicated with MTC or MEN2 history.
- • Pancreatitis — stop and seek care for severe abdominal pain.
- • Gallbladder problems — including gallstones.
- • Hypoglycemia — especially if combined with insulin or sulfonylureas.
- • Kidney injury — from dehydration caused by nausea/vomiting.
Before you enroll: a safety checklist
- What specific medication will you receive? (Brand-name or compounded?)
- Is the prescribing provider licensed in your state?
- How is injectable medication shipped? (Cold chain? Ice packs?)
- What happens if you have a severe side effect?
- What's the cancellation/refund policy before you pay?
- Are the claims on the website consistent with what the provider tells you?
How Hard Is It to Cancel, Pause, or Get Help?
This section matters because cancellation friction is the most common complaint in online reviews of the platform.
Cancellation
You can cancel your subscription through your account dashboard. Hims & Hers support says you should cancel at least 48 hours before your next order processes to avoid being charged for the next cycle. Canceling stops future orders. It does not refund what you've already paid.
Returns and refunds
Per official support documentation: returns are not accommodated due to the nature of the products. This means if you pay $3,594 for a 6-month Wegovy plan and decide after two weeks that the medication isn't for you, you're out $3,594. This is the single biggest risk with the platform.
What real users report
A common pattern in online reviews of Hims & Hers includes:
- • Difficulty reaching customer support and long response times
- • Cancellation friction — reports of being directed to continue treatment rather than having cancellation processed
- • Unexpected charges from not canceling within the 48-hour window
- • Medication shipping delays
Not every customer has this experience. Many are positive about the convenience and affordability. But the pattern is consistent enough to flag.
Our honest advice
Do not enroll assuming you can try this casually and unwind the purchase later. Treat a prepaid plan as a firm commitment. If you're not sure GLP-1 medication is right for you, consider a provider with a month-to-month option first — even if the per-month cost is slightly higher. The flexibility might save you money in the end.
Month-to-Month GLP-1 Options
Lower risk with more flexibility — no long prepaid commitments
- Month-to-month billing available
- No multi-month prepay required
- Higher customer satisfaction ratings
- Cancel anytime without losing thousands
Do Hims and Hers Work in My State, and What About Insurance?
Insurance
Hims & Hers does not accept health insurance. All plans are cash-pay. If your insurance covers brand-name GLP-1 medications like Wegovy or Zepbound, you will almost certainly get a better deal through your primary care doctor or a specialist.
Before choosing telehealth cash-pay, call your insurance and ask: Does my plan cover Wegovy or Zepbound? What's my copay? Do I need prior authorization? If the copay is under $150/month, stop reading and call your doctor.
HSA / FSA
Plans are HSA and FSA eligible. The workflow: pay with a regular card at checkout, download your receipt, submit it to your HSA/FSA administrator for reimbursement. Hims estimates the average savings at about 30% of the plan cost based on average tax rates. See all HSA-friendly GLP-1 providers.
State availability
GLP-1 services through Hims & Hers are not available in all 50 states. Additionally, compounded semaglutide has its own separate state-eligibility list — which historically has not included states like Alabama, Arkansas, Louisiana, or Mississippi based on Hims support documentation. State restrictions for brand-name GLP-1s may differ from compounded restrictions. Check availability on the Hers or Hims website before starting the intake process.
What Most Comparison Pages Get Wrong
They compare them as if they're meaningfully different clinical products
Most pages structure content as "Hers: pros and cons" vs. "Hims: pros and cons," implying there's a real clinical or product difference. Both brands sit under the same parent company with a broadly similar care model. Comparing them as competitors is misleading.
They freeze the story at $199 compounded semaglutide
Most existing reviews and comparisons were written when compounded semaglutide at $199/month was the primary offering. That is no longer the flagship offer being advertised. The platform is shifting toward brand-name FDA-approved medications at different price points.
They gloss over the prepaid commitment
"Starting at $199/month" or "$599/month" sounds like a monthly subscription you can cancel. In reality, most plans require multi-month prepaid, non-refundable payment. A 6-month Wegovy plan is $3,594 committed before you know whether the medication works for you.
They skip the "choose neither" option
The honest answer for some readers is: skip telehealth cash-pay and go to your doctor. If your insurance covers GLP-1s, you can get FDA-approved medication with proper medical oversight for a fraction of the cost.
How We Compared Hers vs Hims for GLP-1
Sources we used:
- • Official Hims (hims.com) and Hers (forhers.com) weight-loss, pricing, and Wegovy pages
- • Hims & Hers investor relations announcements
- • Hims & Hers support documentation (insurance, cancellation, returns, shipping)
- • Novo Nordisk press releases, partnership announcements, and NovoCare pricing
- • FDA drug safety communications, shortage resolution, warning letters, and prescribing information
- • Reuters reporting on the Feb 2026 compounded pill and FDA response
What we verified ourselves:
Pricing on both platforms (March 16, 2026). Cancellation and refund policies via official support documentation. State availability language on current pages. Medication menu references on current live pages. The March 9, 2026 Novo Nordisk announcement terms via the Hims & Hers investor relations page.
What we clearly labeled:
Claims in transition (pricing that's still being finalized post-deal). Claims we could not independently verify. "Provider-stated" vs. "verified by us."
This article is not medical advice. Not a guarantee that you'll see the exact options we describe. Not a claim that every alternative we mention is perfect. Full editorial standards and how we rank.
Frequently Asked Questions: Hers vs Hims GLP-1
Ready to Check the Current Offer?
You've seen the real comparison. You know they're the same parent company. You know the pricing, the commitment terms, the cancellation reality, and the alternatives.
Before you sign up for any GLP-1 provider — do these three things:
- 1Check your insurance first. Call the number on the back of your card and ask if Wegovy or Zepbound is covered. If your copay is under $150/month, go through your doctor. This single step could save you thousands.
- 2Do the real cost math. Don't just look at the monthly rate. Multiply by the plan length. That's your actual commitment. If it doesn't work after two months, are you comfortable having paid the full amount?
- 3Read the cancellation policy before you enter your credit card. Not the marketing page — the actual support documentation.
If Hims & Hers fits your situation
You want virtual access to GLP-1 medication, you're comfortable with cash-pay, and you're ready to commit to a prepaid plan:
Women
Check the current Hers weight loss offer — see what's available for your state, medication options, and pricing before you commit.
See Current Hers GLP-1 OptionsMen
Check the current Hims weight loss offer — same idea, confirm the details before you pay.
See Current Hims GLP-1 OptionsPricing, medication mix, and state availability are actively changing. Confirm the current details during your intake — don't assume what you read last month is still accurate.
If you want more flexibility or better value
Not everyone needs to lock into a multi-month prepaid plan to start GLP-1 medication. We've verified providers offering month-to-month billing, shorter commitments, and insurance navigation — some with meaningfully higher customer satisfaction ratings.
Top-Rated GLP-1 Providers
Month-to-month billing, insurance navigation, and higher satisfaction
- No multi-month prepay required
- Insurance support available
- Month-to-month billing options
- Higher customer satisfaction ratings